Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guedes-Pinto Paste without antibiotic is a modified formulation of the traditional Guedes-Pinto Paste, used as an endodontic filling material for primary (deciduous) teeth. The original paste typically contains iodoform, camphorated paramonochlorophenol (PMCC), prednisolone, and rifamycin. In this antibiotic-free version, rifamycin is omitted due to regulatory restrictions on antibiotics in some regions. The remaining components—iodoform (an antimicrobial agent), camphorated paramonochlorophenol (a disinfectant and antiseptic), and prednisolone (a corticosteroid anti-inflammatory)—work together to provide antimicrobial action and reduce inflammation within the root canal system of primary teeth. This formulation aims to maintain clinical efficacy in pulpectomy procedures while avoiding the use of antibiotics[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guedes-Pinto Paste without antibiotic.